Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B

A Von Drygalski, A Giermasz, G Castaman… - Blood …, 2019 - ashpublications.org
Etranacogene dezaparvovec (AMT-061) is a recombinant AAV5 vector including a gene
cassette containing the factor IX (FIX) Padua variant under the control of a liver-specific …
被引用次数：119 相关文章

[引用][C] Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B

A Von Drygalski, A Giermasz, G Castaman… - Blood …, 2019 - ohsu.elsevierpure.com
Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed
cessation in hemophilia B — Oregon Health & Science University Skip to main navigation …
[PDF] researchgate.net

[PDF][PDF] Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B

A Von Drygalski, A Giermasz, G Castaman, NS Key… - 2019 - researchgate.net
The current standard of care for people with hemophilia B (PWH), namely exogenous
clotting factor replacement, has undergone improvements over recent decades but remains …

Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B

A Von Drygalski, A Giermasz, G Castaman, NS Key… - Blood Advances, 2019 - Elsevier
Etranacogene dezaparvovec (AMT-061) is a recombinant AAV5 vector including a gene
cassette containing the factor IX (FIX) Padua variant under the control of a liver-specific …

Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B.

A Von Drygalski, A Giermasz, G Castaman… - Blood …, 2019 - europepmc.org
Abstract Etranacogene dezaparvovec (AMT-061) is a recombinant AAV5 vector including a
gene cassette containing the factor IX (FIX) Padua variant under the control of a liver-specific …
[PDF] uniqure.com

[PDF][PDF] Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B

A Von Drygalski, A Giermasz, G Castaman, NS Key… - 2019 - uniqure.com
The current standard of care for people with hemophilia B (PWH), namely exogenous
clotting factor replacement, has undergone improvements over recent decades but remains …

Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B

A Von Drygalski, A Giermasz, G Castaman, NS Key… - Blood Advances, 2019 - cir.nii.ac.jp
抄録< jats: p> Etranacogene dezaparvovec (AMT-061) is a recombinant AAV5 vector
including a gene cassette containing the factor IX (FIX) Padua variant under the control of a …

Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B

A Von Drygalski, A Giermasz, G Castaman… - Blood …, 2019 - pubmed.ncbi.nlm.nih.gov
Etranacogene dezaparvovec (AMT-061) is a recombinant AAV5 vector including a gene
cassette containing the factor IX (FIX) Padua variant under the control of a liver-specific …

[引用][C] Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B

AV Drygalski, A Giermasz, G Castaman, NS Key… - Blood Advances, 2019 - repub.eur.nl
RePub, Erasmus University Repository: Etranacogene dezaparvovec (AMT-061 phase 2b):
Normal/near normal FIX activity and bleed cessation in hemophilia B university website Wealth …
[HTML] nih.gov

[HTML][HTML] Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B

A Von Drygalski, A Giermasz, G Castaman… - Blood …, 2019 - ncbi.nlm.nih.gov
Abstract Etranacogene dezaparvovec (AMT-061) is a recombinant AAV5 vector including a
gene cassette containing the factor IX (FIX) Padua variant under the control of a liver-specific …